Advanced Therapy Developers Urged To Monitor Major EU Proposal On Using Blood, Tissues & Cells
Executive Summary
Companies have the opportunity to tell the European Commission what they think about its proposed regulation that would overhaul the rules governing the use of substances of human origin.
You may also be interested in...
EU Proposal Seeks To Address Borderline Product Classification ‘As Early As Possible’
The European Commission’s draft regulation for reforming the EU medicines legislation has proposed a new product classification mechanism for borderline cases where it is not clear if a product is a medicine or falls under another area such as medical devices.
EU Proposal Seeks To Address Borderline Product Classification ‘As Early As Possible’
The European Commission’s draft regulation for reforming the EU medicines legislation has proposed a new product classification mechanism for borderline cases where it is not clear if a product is a medicine or falls under another area such as medical devices.
Swedish EU Presidency Promises Action On Pharma Law Revision, EMA Fees & AMR
Health care and medicines are among the priorities outlined by the new presidency of the Council of the EU for the first half of 2023.